>
Switch to:

Morphic Holding Net Margin %

: -801.57% (As of Sep. 2021)
View and export this data going back to 2019. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Morphic Holding's Net Income for the three months ended in Sep. 2021 was $-25.04 Mil. Morphic Holding's Revenue for the three months ended in Sep. 2021 was $3.12 Mil. Therefore, Morphic Holding's net margin for the quarter that ended in Sep. 2021 was -801.57%.

The historical rank and industry rank for Morphic Holding's Net Margin % or its related term are showing as below:

NAS:MORF' s Net Margin % Range Over the Past 10 Years
Min: -709.68   Med: -255.22   Max: -100.12
Current: -569.4

-709.68
-100.12

NAS:MORF's Net Margin % is ranked lower than
65% of the 998 Companies
in the Biotechnology industry.

( Industry Median: -202.51 vs. NAS:MORF: -569.40 )

Morphic Holding Net Margin % Historical Data

The historical data trend for Morphic Holding's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morphic Holding Annual Data
Trend Dec17 Dec18 Dec19 Dec20
Net Margin %
- -709.68 -255.22 -100.12

Morphic Holding Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.79 -300.78 -651.88 -722.84 -801.57

Competitive Comparison

For the Biotechnology subindustry, Morphic Holding's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Morphic Holding Net Margin % Distribution

For the Biotechnology industry and Healthcare sector, Morphic Holding's Net Margin % distribution charts can be found below:

* The bar in red indicates where Morphic Holding's Net Margin % falls into.



Morphic Holding Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Morphic Holding's Net Margin for the fiscal year that ended in Dec. 2020 is calculated as

Net Margin=Net Income (A: Dec. 2020 )/Revenue (A: Dec. 2020 )
=-44.999/44.945
=-100.12 %

Morphic Holding's Net Margin for the quarter that ended in Sep. 2021 is calculated as

Net Margin=Net Income (Q: Sep. 2021 )/Revenue (Q: Sep. 2021 )
=-25.041/3.124
=-801.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Morphic Holding  (NAS:MORF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Morphic Holding Net Margin % Related Terms

Thank you for viewing the detailed overview of Morphic Holding's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Morphic Holding Business Description

Morphic Holding logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
35 Gatehouse Drive, A2, Waltham, MA, USA, 02451
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.
Executives
Farrell Robert E Jr officer: SVP Finance and CAO CAMBRIDGE DISCOVERY PARK 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Lugovskoy Alexey officer: Chief Development Officer C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Devaul William officer: General Counsel and Secretary C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Slattery Joseph P director C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560
Nashat Amir director 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Stampacchia Otello director 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Springer Timothy A director, 10 percent owner 36 WOODMAN ROAD CHESTNUT HILL MA 02467
Christensen Gustav director DYAX CORP. 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Bischofberger Norbert W director 333 LAKESIDE DR C/O GILEAD SCIENCES, INC. FOSTER CITY CA 94404
Goyal Vikas director C/O SR ONE, LTD., 161 WASHINGTON ST. SUITE 500, EIGHT TOWER BRIDGE CONSHOHOCKEN PA 19428
Rogers Bruce officer: Chief Scientific Officer C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Schegerin Marc officer: CFO and COO ARQULE INC 1 WALL ST FL6 BURLINGTON MA 01803
Linde Peter officer: Chief Medical Officer C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE A2 WALTHAM ME 02451
Tipirneni Praveen P. director, officer: President and CEO C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Omega Fund V Gp, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199

Morphic Holding Headlines

Other Sources

Is Morphic Holding a Buy?

By Fool 2021-04-14

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)